Christopher Hazlitt

Part of Applied UV, Inc., SteriLumen, Inc. is a company that develops and sells disinfection solutions for food safety, preservation, and building hygiene standards. The company is based in Greenwood Village, CO. SteriLumen is committed to delivering solutions that address the unique challenges faced by the food and real estate sectors in the region and beyond. The company offers a portfolio of technologically-advanced air purification and surface disinfection systems. The company was founded by Max Munn.

Endoscopy Center of The Rockies is a medical center that specializes in endocrinology. The private company is based in Lafayette, CO.

SCLH-GI Endoscopy Center Holdings LLC functions as an investment holding private company. The company is based in Louisville, CO.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

The National Collegiate Athletic Association administers intercollegiate sports activities. The company was founded in 1905 and is headquartered in Indianapolis, IN.

First Western Trust Bank is a private banking firm headquartered in Denver, Colorado. The firm was founded by Scott C. Wylie in 2002 and is a subsidiary of First Western Financial, Inc. (NASDAQ: MYFW). First Western Trust offers a unique combination of institutional quality investment management and a variety of financial services including wealth planning, investment management, private banking, personal trust, philanthropic services, retirement consulting, insurance and mortgage services.

Caresyntax Corp. operates surgical analytics and integration services. It offers surgical performance and data driven operating room integration solutions. The company was founded by Dennis Kogan and Bjoern Von Siemens in 2018 and is headquartered in Boston, MA.

Sequel Venture Partners LLC (Sequel Venture Partners) is a venture capital firm founded in 1996 by Kinney Johnson, Daniel Mitchell and Thomas Washing. The firm is headquartered in Boulder, Colorado.

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.

Andarix Pharmaceuticals, Inc. develops and commercializes novel cancer therapies.

Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins and Randall Bellows in 1964 and is headquartered in Lakewood, CO.

Caveo Therapeutics is dedicated to the discovery and development of innovative biopharmaceuticals to treat and cure hematologic conditions. Its technologies identify biological inhibitors that 'guard' receptors on various cell types against excessive or inappropriate activation which can lead to malignancy. Its initial products are designed to inhibit the TAM, Tyro-3, Axl and Mer family of receptor tyrosine kinases, which participate in the blood clotting cascade and are implicated in many cancers including refractory leukemias and lymphomas.

SpringTime Ventures LLC (SpringTime Ventures) is an independent venture capital firm headquartered in Denver, Colorado. The firm was founded in 2016 by Matt Blomstedt and Rick Patch.